Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002969 · ClinicalTrials.gov registry record · Phase 2

S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

A Phase 2 study of Lung Cancer, sponsored by SWOG Cancer Research Network.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
20
Study locations

NCT00002969 is a Phase 2 study of Lung Cancer that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 60 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002969, a Phase 2 study of Lung Cancer, has completed, sponsored by SWOG Cancer Research Network.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chemotherapy with paclitaxel in treating patients with stage IIIB or stage IV non-small cell lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • DRUG paclitaxel

Study Locations (20)

California

  • Beckman Research Institute, City of Hope - Duarte
  • Veterans Affairs Medical Center - Long Beach - Long Beach
  • USC/Norris Comprehensive Cancer Center - Los Angeles
  • Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
  • Veterans Affairs Outpatient Clinic - Martinez - Martinez
  • CCOP - Bay Area Tumor Institute - Oakland
  • University of California Davis Medical Center - Sacramento
  • UCSF Cancer Center and Cancer Research Institute - San Francisco
  • CCOP - Santa Rosa Memorial Hospital - Santa Rosa
  • David Grant Medical Center - Travis Air Force Base

Arizona

  • CCOP - Greater Phoenix - Phoenix
  • Veterans Affairs Medical Center - Phoenix (Hayden) - Phoenix
  • Veterans Affairs Medical Center - Tucson - Tucson
  • Arizona Cancer Center - Tucson

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock
  • Veterans Affairs Medical Center - Little Rock (McClellan) - Little Rock

Colorado

  • Veterans Affairs Medical Center - Denver - Denver
  • University of Colorado Cancer Center - Denver

Alabama

  • MBCCOP - University of South Alabama - Mobile

Georgia

  • CCOP - Atlanta Regional - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 1997-05
Est. Completion 2007-01
Phase Phase 2

Sponsor

SWOG Cancer Research Network

270 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002969

The ClinicalTrials.gov registry entry for NCT00002969 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which paclitaxel is the first listed.

NCT00002969 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Arizona, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00002969 about?

NCT00002969 is a clinical study titled "S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chemotherapy with paclitaxel in treating patients with stage IIIB or stage IV non-small cell lung cancer.

What is the current status of trial NCT00002969?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 1997-05. Estimated completion is 2007-01.

What conditions does trial NCT00002969 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00002969?

The interventions under investigation include: paclitaxel (DRUG).

Who is sponsoring clinical trial NCT00002969?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002969 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.